ArticlePloS one2013

Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Elizabeth Singer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.